U.S. Paper and Forestry Products Stock News

In recent days, Clear Secure has drawn heightened attention as a frequently searched stock, with analysts and institutional investors emphasizing its consistent outperformance versus earnings and revenue estimates despite an anticipated year-over-year decline in current-quarter EPS to $0.31. Portfolio recognition from Meridian Hedged Equity Fund and continued confidence from Telsey Advisory Group highlight Clear Secure’s positioning as an innovator in biometric identity verification and...

If you are wondering whether GE HealthCare Technologies is fairly priced today, this article walks through what the current share price might be implying about its underlying value. The stock last closed at US$82.95, with returns of 4.7% over the past week, 1.5% over the past month, a small 0.2% gain year to date, and a 10.2% decline over the past year. These moves may have some investors reassessing the balance between upside potential and risk. Recent attention on GE HealthCare has focused...

In February 2026, TriNet Group reported fourth-quarter 2025 revenue of US$1,248 million with a net loss of US$1 million, and full-year 2025 revenue of US$5,010 million with net income of US$155 million, alongside new 2026 guidance and an update on its long-running share repurchase program. The company’s 2026 outlook, which points to lower total revenue of US$4,750 million to US$4,900 million and reduced diluted earnings per share of US$2.15 to US$3.05, raises fresh questions about how its...

TransMedics Group received full FDA approval for its Next-Generation OCS ENHANCE Heart trial Investigational Device Exemption. The trial is designed to assess the company’s Organ Care System Heart technology for prolonged heart perfusion versus current storage methods. This FDA decision marks a material development for NasdaqGM:TMDX and its organ transplant platform. TransMedics Group, trading on NasdaqGM:TMDX, now has a fresh regulatory green light that adds to its profile in the heart...

If you are wondering whether Krystal Biotech's share price reflects its true worth, this article will walk through how the current market price compares with a range of valuation checks. The stock last closed at US$283.29, with returns of 3.9% over 7 days, 14.7% year to date, and 60.8% over the past year. This performance has put it firmly on many investors' radar. Recent interest in Krystal Biotech has been shaped by ongoing attention to its gene therapy pipeline and regulatory milestones...

Similarweb (SMWB) has wrapped up FY 2025 with Q4 revenue of US$72.8 million and a basic EPS loss of US$0.09, alongside net income excluding extra items of a US$7.5 million loss. The company has seen revenue move from US$65.6 million in Q4 2024 to US$72.8 million in Q4 2025, while quarterly basic EPS shifted from a US$0.07 loss to a US$0.09 loss over the same period. This sets up a story focused on how quickly margins can tighten or ease from here. See our full analysis for Similarweb. With...

Event overview and why it matters for CRA International (CRAI) CRA International (CRAI) is stepping in to manage an RFP auction for FirstEnergy Corp.'s Ohio subsidiaries, helping them secure full requirements service for Percentage of Income Payment Plan customers. This utility sector assignment highlights CRAI's role in complex auction design and execution, giving investors another concrete example of how its consulting capabilities are used in regulated energy markets. See our latest...

If you are wondering whether Delta Air Lines is fairly priced or if the current share price leaves some value on the table, this article will walk you through what the numbers are saying about the stock. Delta’s share price recently closed at US$71.11, with returns of 10.6% over 1 year, 3.0% year to date, 1.0% over 30 days, and a 0.4% decline over the last 7 days. These figures may hint at shifting views on its growth prospects and risk. Recent headlines around Delta have focused on broader...

In recent months, Annaly Capital Management declared first-quarter 2026 cash dividends on its Series F, G, I and J preferred shares, while reporting that no shares were repurchased under the buyback program announced in January 2025. The combination of floating-rate preferred dividends tied to three‑month CME Term SOFR and an unused buyback program highlights how Annaly is prioritizing income distributions within a changing interest rate backdrop and capital allocation framework. We’ll now...

In early February 2026, Grindr’s majority shareholder James Fu Bin Lu sold 1.45 million shares for about US$14.6 million after buyout talks to take the company private ended over financing concerns, while the company also came under investigation into potential board fiduciary breaches. At the same time, Grindr began piloting its high-priced AI-powered “Edge” subscription, testing whether users will pay materially more for personalized matches and insights. We’ll explore how the majority...

Why the CFO transition matters for First BanCorp stock First BanCorp (FBP) has announced a planned finance leadership handoff, with long-serving Chief Financial Officer Orlando Berges set to retire in 2026 and current Chief Accounting Officer Said Ortiz stepping into the CFO role. For you as an investor, this type of internally sourced transition often raises questions about continuity in financial policy, capital allocation, and risk management, especially at a bank, where the finance...

In recent days, MercadoLibre has accelerated spending on logistics, free shipping, and its Mercado Pago fintech platform across Latin America to strengthen its position against intensifying competition from Sea Limited, JD.com, and others. This push to deepen logistics coverage and financial services reach is reshaping the balance between growth investment and near-term profitability across MercadoLibre’s ecosystem. We’ll now examine how MercadoLibre’s heavier logistics and fintech...

Moody's (MCO) has just posted third quarter FY 2025 revenue of US$2.0b and basic EPS of US$3.61, with trailing twelve month revenue at US$7.5b and EPS at US$12.48 framing the latest print within a larger earnings run rate. The company has seen quarterly revenue move from US$1.82b in Q2 2024 to US$1.90b in Q2 2025 and then US$2.01b in Q3 2025, while basic EPS moved from US$3.03 to US$3.22 and then US$3.61 over the same quarters, giving investors a clear view of how the income statement is...

LiveRamp Holdings (RAMP) drew fresh investor attention after appointing Kristi Argyilan, Global Head of Advertising at Uber, to its Board of Directors, highlighting her long track record in retail media and advertising leadership. See our latest analysis for LiveRamp Holdings. That board appointment comes after a busy few weeks for LiveRamp, with solid third quarter earnings, fresh guidance and ongoing share buybacks drawing attention to a share price that has a 7 day share price return of...

Viking Therapeutics reported a full-year 2025 net loss of US$359.64 million, with basic loss per share widening to US$3.19 from US$1.01 a year earlier, and disclosed that it executed no share repurchases under its previously announced buyback program. At the same time, the company is pushing its obesity pipeline forward, including phase 3 development of injectable VK2735 and planned late-stage trials for its oral counterpart and a dual amylin–calcitonin receptor agonist. We’ll now examine...

Goosehead Insurance (GSHD) closed FY 2025 with fourth quarter revenue of US$105.3 million and basic EPS of US$0.50, alongside trailing twelve month revenue of US$365.3 million and EPS of US$1.11 that frame the latest print in a wider context of reported earnings. Over the past six quarters, revenue has moved from US$77.8 million in Q3 2024 to US$105.3 million in Q4 2025, while quarterly EPS has ranged from US$0.09 in Q1 2025 to US$0.60 in Q4 2024. This gives investors a clearer view of how...

In February 2026, Diebold Nixdorf reported that it had completed two share repurchase programs totaling 2,307,275 shares for US$150.57 million and announced fourth-quarter 2025 net income of US$49.6 million, with full-year 2025 net income of US$94.6 million following a loss a year earlier. At the same time, Arena Capital Advisors fully exited its roughly US$35 million position, meaning improved profitability and capital returns are unfolding alongside a complete withdrawal by one of the...

Fiverr International (FVRR) just posted its FY 2025 numbers with Q3 revenue of US$107.9 million and basic EPS of US$0.15, set against trailing twelve month revenue of US$427.4 million and EPS of US$0.62 that reflect earnings growth of 121.2% over the past year. The company has seen quarterly revenue move from US$94.7 million in Q2 2024 to a range of roughly US$107 million to US$108.6 million across the first three quarters of 2025. Over the same 2025 periods, basic EPS shifted from US$0.09 in...

If you are wondering whether Oddity Tech's share price reflects its true potential, this article walks through how the current market price lines up with several valuation checks. The stock last closed at US$29.98, with a 2.8% return over the past 7 days, a 15.3% decline over 30 days, and a 24.0% decline year to date, while the 1 year return sits at a 32.6% decline. Recent coverage of Oddity Tech has focused on its position within the household and beauty space, including how its digital...

If you are wondering whether PG&E's current share price reflects its true value, you are not alone. Many investors are asking the same question as the stock trades around US$17.88. Over the short to medium term, PG&E has recorded returns of 4.6% over 7 days, 14.5% over 30 days, 9.9% year to date, 15.1% over 1 year and 16.5% over 3 years, while the 5 year figure stands at 58.5%. Recent headlines around PG&E have continued to focus on the company and its role in the California utilities...

In February 2026, Teradata reported its fourth-quarter and full-year 2025 results, showing modest year-over-year revenue growth in Q4 to US$421 million, higher quarterly and annual net income, and improved diluted EPS alongside updated 2026 guidance calling for broadly flat revenue and earnings in the range of US$0.36–US$0.40 for Q1 and US$1.26–US$1.36 for the full year. Management also highlighted stronger customer uptake of Teradata’s AI-focused and hybrid cloud offerings, while the...

Starboard Value has launched an activist campaign targeting Tripadvisor's board, seeking to replace a majority of directors. The investor is urging Tripadvisor to consider options to maximize shareholder value, including a possible sale of the company. Starboard has criticized Tripadvisor's strategic direction, use of Generative AI, and past decisions it views as unfavorable to shareholders. For anyone tracking NasdaqGS:TRIP, this campaign comes after a challenging stretch for the stock...

Bausch Health Companies (NYSE:BHC) is back in focus after reporting its eleventh consecutive quarter of revenue and adjusted EBITDA growth, while posting a quarterly net loss and missing earnings expectations. See our latest analysis for Bausch Health Companies. Despite the recent earnings miss and quarterly net loss, investors have reacted with a 1-day share price return of 3.34% to US$6.19. However, the 30-day share price return of 11.32% and year-to-date share price return of 14.15%...

IDEAYA Biosciences (IDYA) has wrapped up FY 2025 with Q4 revenue of US$10.9 million, a basic EPS loss of US$0.94, and net income excluding extra items at a loss of US$83.3 million. Trailing twelve month figures show revenue of US$218.7 million and a basic EPS loss of US$1.28. Over recent quarters, the company’s revenue moved from US$7.0 million in Q4 2024 to US$207.8 million in Q3 2025 before landing at US$10.9 million in Q4 2025. Basic EPS ranged from a loss of US$1.49 in Q4 2024 to a profit...